£139.53

Springer Adverse Events with Biomedicines: Prevention Through Understanding

15 black & white tables, biography

Price data last checked 49 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£140 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 42 days • 42 data points (No recent data available)

Historical
Generating forecast...
£139.53 £132.55 £135.34 £138.13 £140.93 £143.72 £146.51 11 March 2026 21 March 2026 31 March 2026 10 April 2026 21 April 2026

Price Distribution

Price distribution over 42 days • 1 price levels

Days at Price
42 days 0 11 21 32 42 £140 Days at Price

Price Analysis

Most common price: £140 (42 days, 100.0%)

Price range: £140 - £140

Price levels: 1 different prices over 42 days

Description

This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those “biomedicines” – monoclonal antibodies, fusion proteins, and cytokines – that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered. Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)
95% match

Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)

Springer

£86.66 26 Jan 2026
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
95% match

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£68.52 08 Mar 2026
Biologics and Biosimilars: Drug Discovery and Clinical Applications
95% match

Biologics and Biosimilars: Drug Discovery and Clinical Applications

CRC Press

£45.07 07 Feb 2026
Introduction to Antibody Engineering (Learning Materials in Biosciences)
95% match

Introduction to Antibody Engineering (Learning Materials in Biosciences)

Springer

£57.66 27 Feb 2026
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
95% match

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

CRC Press

£250.00 13 Jan 2026
Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins
95% match

Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins

Springer

£85.37 08 Mar 2026
Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)
95% match

Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)

Humana

£59.92 08 Mar 2026
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
95% match

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

CRC Press

£62.59 24 Feb 2026
Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)
95% match

Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)

Springer

£53.50 10 Mar 2026
Human Monoclonal Antibodies: Methods and Protocols: 1060 (Methods in Molecular Biology, 1060)
95% match

Human Monoclonal Antibodies: Methods and Protocols: 1060 (Methods in Molecular Biology, 1060)

Humana

£103.71 07 Jan 2026
Biopharmaceuticals, an Industrial Perspective
95% match

Biopharmaceuticals, an Industrial Perspective

Springer

£221.39 13 Jan 2026
Bispecific Antibodies
95% match

Bispecific Antibodies

Springer

£144.96 31 Jan 2026
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics
95% match

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Academic Press

£105.79 17 Feb 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
95% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

£95.00 09 Dec 2025
Biopharmaceuticals, an Industrial Perspective
95% match

Biopharmaceuticals, an Industrial Perspective

Springer

£212.92 21 Jan 2026
Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)
95% match

Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)

Springer

£47.42 10 Mar 2026
Vaccine Adjuvants: Methods and Protocols: 1494 (Methods in Molecular Biology, 1494)
95% match

Vaccine Adjuvants: Methods and Protocols: 1494 (Methods in Molecular Biology, 1494)

Humana

£79.93 05 Feb 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
95% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£160.28 22 Feb 2026
Antibody Engineering: Methods and Protocols: 248 (Methods in Molecular Biology, 248)
95% match

Antibody Engineering: Methods and Protocols: 248 (Methods in Molecular Biology, 248)

Humana

£109.64 15 Dec 2025
Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
95% match

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Springer

£160.00 13 Jan 2026
Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
95% match

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

£179.10 13 Jan 2026
Biopharmaceuticals: Biochemistry and Biotechnology
95% match

Biopharmaceuticals: Biochemistry and Biotechnology

Wiley-Blackwell

£95.00 07 Mar 2026
Development of Antibody-Based Therapeutics: Translational Considerations & Challenges
95% match

Development of Antibody-Based Therapeutics: Translational Considerations & Challenges

Adis

£103.81 13 Jan 2026
Recombinant Antibodies for Immunotherapy
94% match

Recombinant Antibodies for Immunotherapy

Cambridge University Press

£39.99 20 Apr 2026